BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hao Z, Guo D. EGFR mutation: novel prognostic factor associated with immune infiltration in lower-grade glioma; an exploratory study. BMC Cancer 2019;19:1184. [PMID: 31801484 DOI: 10.1186/s12885-019-6384-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Hong X, Zhang J, Zou J, Ouyang J, Xiao B, Wang P, Peng X. Role of COL6A2 in malignant progression and temozolomide resistance of glioma. Cell Signal 2023;102:110560. [PMID: 36521657 DOI: 10.1016/j.cellsig.2022.110560] [Reference Citation Analysis]
2 Landau J, Tsaban L, Yaacov A, Ben Cohen G, Rosenberg S. Shared Cancer Dataset Analysis Identifies and Predicts the Quantitative Effects of Pan-Cancer Somatic Driver Variants. Cancer Res 2023;83:74-88. [PMID: 36264175 DOI: 10.1158/0008-5472.CAN-22-1038] [Reference Citation Analysis]
3 Xu J, Sun S, Zhang W, Dong J, Huang C, Wang X, Jia M, Yang H, Wang Y, Jiang Y, Cao L, Huang Z. Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1027577] [Reference Citation Analysis]
4 Zhang Z, Lai G, Sun L. Basement-Membrane-Related Gene Signature Predicts Prognosis in WHO Grade II/III Gliomas. Genes 2022;13:1810. [DOI: 10.3390/genes13101810] [Reference Citation Analysis]
5 Shi J, Wang L, Yin X, Wang L, Bo L, Liu K, Feng K, Lin S, Xu Y, Ning S, Zhao H. Comprehensive characterization of clonality of driver genes revealing their clinical relevance in colorectal cancer. J Transl Med 2022;20:362. [PMID: 35962343 DOI: 10.1186/s12967-022-03529-x] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Bai M, Wang X, Zhang H, Wang J, Lyaysan G, Xu S, Tian K, Wang T, Li J, Wang N, Lu X, Zhang X, Wang L, Hu W. Dissecting and analyzing the Subclonal Mutations Associated with Poor Prognosis in Diffuse Glioma. BioMed Research International 2022;2022:1-19. [DOI: 10.1155/2022/4919111] [Reference Citation Analysis]
7 Zhou Z, Wei J, Jiang W. Characterization of aging tumor microenvironment with drawing implications in predicting the prognosis and immunotherapy response in low-grade gliomas. Sci Rep 2022;12:5457. [PMID: 35361903 DOI: 10.1038/s41598-022-09549-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 He Q, Zhao W, Ren Q. The Prognostic Value of the Prognostic Nutritional Index in Operable High-Grade Glioma Patients and the Establishment of a Nomogram. Front Oncol 2021;11:724769. [PMID: 35096561 DOI: 10.3389/fonc.2021.724769] [Reference Citation Analysis]
9 Hernández A, Domènech M, Muñoz-mármol AM, Carrato C, Balana C. Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment. Cells 2021;10:3529. [DOI: 10.3390/cells10123529] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Noor H, Zaman A, Teo C, Sughrue ME. PODNL1 Methylation Serves as a Prognostic Biomarker and Associates with Immune Cell Infiltration and Immune Checkpoint Blockade Response in Lower-Grade Glioma. Int J Mol Sci 2021;22:12572. [PMID: 34830454 DOI: 10.3390/ijms222212572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Nguyen H, Tran D, Tran B, Roy M, Cassell A, Dascalu S, Draghici S, Nguyen T. SMRT: Randomized Data Transformation for Cancer Subtyping and Big Data Analysis. Front Oncol 2021;11:725133. [PMID: 34745946 DOI: 10.3389/fonc.2021.725133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ma X, Chen H, Yang M, Ke Z, Wang M, Huang T, Li L. Classification of Estrogen Receptor-Positive Breast Cancer Based on Immunogenomic Profiling and Validation at Single-Cell Resolution. Front Cell Dev Biol 2021;9:722841. [PMID: 34621742 DOI: 10.3389/fcell.2021.722841] [Reference Citation Analysis]
13 Śledzińska P, Bebyn MG, Furtak J, Kowalewski J, Lewandowska MA. Prognostic and Predictive Biomarkers in Gliomas. Int J Mol Sci 2021;22:10373. [PMID: 34638714 DOI: 10.3390/ijms221910373] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
14 Zhang H, Xu L, Zhong Z, Liu Y, Long Y, Zhou S. Lower-Grade Gliomas: Predicting DNA Methylation Subtyping and its Consequences on Survival with MR Features. Acad Radiol 2021;28:e199-208. [PMID: 32241714 DOI: 10.1016/j.acra.2020.02.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Mei J, Cai Y, Xu R, Yang X, Zhou W, Wang H, Liu C. Characterization of the Clinical Significance of PD-1/PD-Ls Expression and Methylation in Patients With Low-Grade Glioma. Technol Cancer Res Treat 2021;20:15330338211011970. [PMID: 33955303 DOI: 10.1177/15330338211011970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
16 Chang CY, Pan PH, Wu CC, Liao SL, Chen WY, Kuan YH, Wang WY, Chen CJ. Endoplasmic Reticulum Stress Contributes to Gefitinib-Induced Apoptosis in Glioma. Int J Mol Sci 2021;22:3934. [PMID: 33920356 DOI: 10.3390/ijms22083934] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
17 Xuan W, Lesniak MS, James CD, Heimberger AB, Chen P. Context-Dependent Glioblastoma-Macrophage/Microglia Symbiosis and Associated Mechanisms. Trends Immunol 2021;42:280-92. [PMID: 33663953 DOI: 10.1016/j.it.2021.02.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
18 Vazquez N, Lopez A, Cuello V, Persans M, Schuenzel E, Innis-Whitehouse W, Keniry M. NVP-BEZ235 or JAKi Treatment leads to decreased survival of examined GBM and BBC cells. Cancer Treat Res Commun 2021;27:100340. [PMID: 33636591 DOI: 10.1016/j.ctarc.2021.100340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 González-Tablas Pimenta M, Otero Á, Arandia Guzman DA, Pascual-Argente D, Ruíz Martín L, Sousa-Casasnovas P, García-Martin A, Roa Montes de Oca JC, Villaseñor-Ledezma J, Torres Carretero L, Almeida M, Ortiz J, Nieto A, Orfao A, Tabernero MD. Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome. Brain Pathol 2021;31:365-80. [PMID: 33314398 DOI: 10.1111/bpa.12927] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
20 Wang P, Zhang J, He S, Xiao B, Peng X. SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas. Cancer Cell Int 2020;20:573. [PMID: 33292262 DOI: 10.1186/s12935-020-01675-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
21 Zhang L, Wang Y, Li X, Wang Y, Wu K, Wu J, Liu Y. Identification of a Recurrence Signature and Validation of Cell Infiltration Level of Thyroid Cancer Microenvironment. Front Endocrinol (Lausanne) 2020;11:467. [PMID: 32793117 DOI: 10.3389/fendo.2020.00467] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
22 Gargini R, Segura-Collar B, Sánchez-Gómez P. Cellular Plasticity and Tumor Microenvironment in Gliomas: The Struggle to Hit a Moving Target. Cancers (Basel) 2020;12:E1622. [PMID: 32570988 DOI: 10.3390/cancers12061622] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
23 Mei J, Cai Y, Xu R, Yang X, Zhou W, Wang H, Liu C. Characterization of clinical significance of PD-1/PD-Ls expression and methylation in patients with low grade glioma.. [DOI: 10.1101/2020.03.20.999573] [Reference Citation Analysis]
24 Arcella A, Limanaqi F, Ferese R, Biagioni F, Oliva MA, Storto M, Fanelli M, Gambardella S, Fornai F. Dissecting Molecular Features of Gliomas: Genetic Loci and Validated Biomarkers. Int J Mol Sci 2020;21:E685. [PMID: 31968687 DOI: 10.3390/ijms21020685] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]